SCHEMBL18219006

SCHEMBL18219006

CC(=O)C[C@H](OC(C)=O)C(=O)O

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALOX15 P16050 1/20 0.41
TDP1 Q9NUW8 2/20 0.40
TSHR P16473 2/20 0.40
ALDH1A1 P00352 1/20 0.40
SMN1; SMN2 Q16637 2/20 0.38
LMNA P02545 1/20 0.38
CHRM2 P08172 1/20 0.35
CHRM4 P08173 1/20 0.35
CHRM1 P11229 1/20 0.35
TBXA2R P21731 1/20 0.35
GALR3 O60755 1/20 0.34
MAPT P10636 1/20 0.34
BLM P54132 1/20 0.34
MEN1 O00255 1/20 0.34
CYP1A2 P05177 1/20 0.34
HRH1 P35367 1/20 0.34
KMT2A Q03164 1/20 0.34
MMP1 P03956 1/20 0.33
MMP2 P08253 1/20 0.33
MMP3 P08254 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18908300 1.00 ALOX15 (0.41) ALOX15TDP1TSHRALDH1A1SMN1; SMN2
SCHEMBL18219051 1.00 ALOX15 (0.41) ALOX15TDP1TSHRALDH1A1SMN1; SMN2
SCHEMBL29000852 0.86 ALOX15 (0.50) ALOX15TDP1TSHRSMN1; SMN2LMNA
SCHEMBL581924 0.86 ALOX15 (0.50) ALOX15TDP1TSHRSMN1; SMN2LMNA
SCHEMBL5310540 0.86 ALOX15 (0.50) ALOX15TDP1TSHRSMN1; SMN2LMNA
Naphthalene SCHEMBL8410868 0.85 PPARG (0.45) ALDH1A1SMN1; SMN2MMP12PPARGPPARA
Hydrochloric Acid SCHEMBL10892024 0.84 ALOX15 (0.48) ALOX15TDP1TSHRSMN1; SMN2LMNA
SCHEMBL6560774 0.82 ALOX15 (0.38) ALOX15TDP1TSHRALDH1A1SMN1; SMN2
SCHEMBL11444914 0.82 ALOX15 (0.38) ALOX15TDP1TSHRALDH1A1SMN1; SMN2
SCHEMBL13345401 0.80 MGAM (0.39) ALOX15TDP1TSHRALDH1A1SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20170157116-A1 METHODS AND COMPOSITIONS FOR PREVENTING OPIOID ABUSE CURIA BUFFALO R&D, LLC 2017-06-08 US disclosed
US-20170151232-A1 METHODS AND COMPOSITIONS FOR PREVENTING OPIOID ABUSE CURIA BUFFALO R&D, LLC 2017-06-01 US disclosed
US-20160326182-A1 METHODS AND COMPOSITIONS FOR PREVENTING OPIOID ABUSE CURIA BUFFALO R&D, LLC 2016-11-10 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160326182-A1 METHODS AND COMPOSITIONS FOR PREVENTING OPIOID ABUSE OPRM1, OPRK1, OPRD1 ALOX15 879/4885TDP1 3101/4885TSHR 4761/4885
US-20170157116-A1 METHODS AND COMPOSITIONS FOR PREVENTING OPIOID ABUSE OPRM1, OPRK1, OPRD1 ALOX15 879/4885TDP1 3101/4885TSHR 4761/4885
US-20170151232-A1 METHODS AND COMPOSITIONS FOR PREVENTING OPIOID ABUSE OPRM1, OPRK1, OPRD1 ALOX15 879/4885TDP1 3101/4885TSHR 4761/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.